Examining attitudes to psilocybin: Should candidates for medical psilocybin be required to pass a contextual suitability test

The abstract of this free, full-text preprint reads: "Background: Due to increasing evidence of efficacy in treating mental health disorders, psilocybin may become a legal medicinal drug. This study tested the validity of Carhart-Harris & Nutt (2017) model of extra-pharmacological (EP) factors and examined whether such factors should be taken into account in any psychological suitability test for medicinally prescribed psilocybin.  Method: 219 participants (101 self-identified females, 109 males, 7 non-binary people and 2 who preferred not to say), with an age range of 18 to 68, completed three online measures of ‘personality’; ‘set, setting and intention’, and the ‘Attitudes Towards Psilocybin’ (ATP) scale. The sample was equally divided between those who had used psychedelics (52.1%) and those who had no previous psychedelic use (47.5%). A series of stepwise linear regressions were run to examine of extra-pharmcological factor predictors of ATP.  Results: The ATP scale was tested in terms of its reliability, construct validity, determinant validity and was deemed an appropriate measure. A model consisting of Set, Openness to Experience and Extraversion significantly predicted ATP scores.  Conclusion: These findings supported the EP model and suggest that a suitability test may be a useful tool when determining whether a prescription of psilocybin is an appropriate course of treatment."

For more psychedelic news and research, visit the psychedelic health professional network homepage.

Previous
Previous

The readiness of psychiatrists to implement psychedelic-assisted psychotherapy

Next
Next

A semantic scale network analysis of the revised Mystical Experiences Questionnaire: A call for collaboration